| Synergistic effects of social media and traditional marketing on brand sales: Capturing the time-varying effects V Kumar, JWB Choi, M Greene Journal of the Academy of marketing Science 45, 268-288, 2017 | 292 | 2017 |
| The economic burden of bipolar I disorder in the United States in 2015 M Cloutier, M Greene, A Guerin, M Touya, E Wu Journal of affective disorders 226, 45-51, 2018 | 191 | 2018 |
| Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder M Greene, T Yan, E Chang, A Hartry, M Touya, MS Broder Journal of medical economics 21 (2), 127-134, 2018 | 176 | 2018 |
| The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey R Tandon, WR Lenderking, C Weiss, H Shalhoub, CD Barbosa, J Chen, ... Annals of general psychiatry 19, 1-11, 2020 | 55 | 2020 |
| Medication adherence and discontinuation of aripiprazole once-monthly 400 mg (AOM 400) versus oral antipsychotics in patients with schizophrenia or bipolar I disorder: a real … T Yan, M Greene, E Chang, A Hartry, M Touya, MS Broder Advances in therapy 35, 1612-1625, 2018 | 45 | 2018 |
| Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA M Greene, L Paladini, T Lemmer, A Piedade, M Touya, O Clark Neuropsychiatric disease and treatment, 1545-1559, 2018 | 40 | 2018 |
| Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real … J Munday, M Greene, E Chang, A Hartry, T Yan, MS Broder Current Medical Research and Opinion, 2019 | 36 | 2019 |
| Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder T Yan, M Greene, E Chang, M Touya, MS Broder Journal of Comparative Effectiveness Research 7 (11), 1083-1093, 2018 | 16 | 2018 |
| All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics T Yan, M Greene, E Chang, A Hartry, M Touya, MS Broder Current Medical Research and Opinion 34 (1), 41-47, 2018 | 16 | 2018 |
| Atypical antipsychotic adherence is associated with lower inpatient utilization and cost in bipolar I disorder MS Broder, M Greene, E Chang, A Hartry, T Yan, I Yermilov Journal of Medical Economics 22 (1), 63-70, 2019 | 14 | 2019 |
| Health care resource use, costs, and diagnosis patterns in patients with schizophrenia and bipolar disorder: real-world evidence from US claims databases MS Broder, M Greene, E Chang, A Hartry, M Touya, J Munday, T Yan Clinical therapeutics 40 (10), 1670-1682, 2018 | 13 | 2018 |
| Evaluation of patient support program and adherence to long-acting injectable aripiprazole for patients utilizing injection local care centers M Greene, C Burudpakdee, A Seetasith, M Behling, H Krasa Current Medical Research and Opinion 35 (1), 97-103, 2019 | 12 | 2019 |
| Outcomes associated with nonconcordance to National Kidney Foundation guideline recommendations for oral antidiabetic drug treatments in patients with concomitant type 2 … SY Chen, YC Lee, V Alas, M Greene, D Brixner Endocrine Practice 20 (3), 221-231, 2014 | 12 | 2014 |
| Hospitalization risk factors in antipsychotic-treated schizophrenia, bipolar I disorder or major depressive disorder T Yan, M Greene, E Chang, MS Broder, M Touya, J Munday, A Hartry Journal of Comparative Effectiveness Research 8 (4), 217-227, 2019 | 11 | 2019 |
| Usefulness of investigation in a first seizure clinic N Hitiris, JP Leach, R Mokanrav, A Mallik, J Greene, R Duncan JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 76 (9), 1316-1316, 2005 | 11 | 2005 |
| Outcomes associated with concordance of oral antidiabetic drug treatments to prescribing information in patients with type 2 diabetes mellitus and chronic kidney disease SY Chen, YC Lee, V Alas, M Greene, D Brixner Journal of Medical Economics 16 (5), 586-595, 2013 | 10 | 2013 |
| Evaluation of the Prevalence of Chronic Kidney Disease and Rates of Oral Antidiabetic Prescribing in Accordance with Guidelines and Manufacturer Recommendations in Type 2 … N Wu, X Yu, M Greene, G Oderda International Journal of Nephrology 2014 (1), 151706, 2014 | 9 | 2014 |
| Medication adherence, health care utilization, and costs in patients with major depressive disorder initiating adjunctive atypical antipsychotic treatment MS Broder, M Greene, T Yan, E Chang, A Hartry, I Yermilov Clinical Therapeutics 41 (2), 221-232, 2019 | 7 | 2019 |
| Cost–effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA M Augusto, M Greene, M Touya, SM Sweeney, H Waters Journal of Comparative Effectiveness Research 7 (7), 637-650, 2018 | 7 | 2018 |
| Earlier versus later augmentation with an antipsychotic medication in patients with major depressive disorder demonstrating inadequate efficacy in response to antidepressants … I Yermilov, M Greene, E Chang, A Hartry, T Yan, MS Broder Advances in Therapy 35, 2138-2151, 2018 | 6 | 2018 |
